MyFinsight
Home
Blog
About
Back
Cash Flow
Kairos Pharma, LTD. (KAPA)
Kairos Pharma, LTD. (KAPA)
source: myfinsight.com
Net increase
(decrease) in cash and cash...
-$1,049K
(-159.53%↓ Y/Y)
Fair value of vested
restricted stock units
$259K
(69.28%↑ Y/Y)
Amortization of vendor
advances
$213K
(-83.59%↓ Y/Y)
Amortization of intangible
asset
$22K
(-72.50%↓ Y/Y)
Prepaid expenses and
other current assets
-$7K
(-114.00%↓ Y/Y)
Proceeds from the at the
market (atm) offering
$7K
Net cash used in
operating activities
-$1,012K
(33.38%↑ Y/Y)
Net cash provided by
financing activities
-$37K
(-101.13%↓ Y/Y)
Canceled cashflow
$501K
Canceled cashflow
$7K
Net loss
-$1,388K
(48.29%↑ Y/Y)
Payment of deferred
offering costs
$44K
Accounts payable and
accrued expenses
-$125K
(60.44%↑ Y/Y)
Back